ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106246 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106246; 2) Community: the network communities that were significantly associated with the response to NSC 106246; 3) Molecule: the relationships between components within communities and NSC 106246; 4) MDR: the compounds that were significantly associated with the NSC 106246.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0237269271456697 -0.3872907
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.2363325
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.0237269271456697 0.019607914
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0237269271456697 0.36350553
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0237269271456697 0.26166565
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0237269271456697 0.40224838
NSC 81280 Null 0.0237269271456697 0.2874899
NSC 87864 N-Salicylidene-N-salicyloylhydrazine 0.0237269271456697 0.027206983
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0291420747327558 0.2369714
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0291420747327558 0.021356524
Total:72  Current:40    [First] [Prev] [Next] [Last]